ECG in suspected pulmonary embolism by Thomson, Duncan et al.
  
 
 
 
 
Thomson, D., Kourounis, G., Trenear, R., Messow, C.-M., Hrobar, P., Mackay, A. and 
Isles, C. (2019) ECG in suspected pulmonary embolism. Postgraduate Medical Journal, 
(doi:10.1136/postgradmedj-2018-136178). 
 
   
There may be differences between this version and the published version. You are 
advised to consult the publisher’s version if you wish to cite from it. 
 
 
 
http://eprints.gla.ac.uk/178704/  
      
 
 
 
 
 
 
Deposited on: 29 January 2019 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
 1 
The ECG in Suspected Pulmonary Embolism 
Duncan Thomson1, Georgios Kourounis1, Rebecca Trenear1, Claudia-Martina Messow2, Petr 
Hrobar3, Alistair Mackay4, Chris Isles1. 
Departments of Medicine1, Radiology3 and Cardiology4, Dumfries Royal Infirmary, 
Dumfries DG2 8RX; Robertson Centre for Biostatistics2, University of Glasgow, Glasgow 
G12 8QQ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
Abstract 
Objective – To establish the diagnostic value of prespecified ECG changes in suspected PE.  
Methods – Retrospective case control study in a district general hospital setting.  We 
identified 189 consecutive patients with suspected pulmonary embolism (PE) whose CT 
pulmonary angiogram (CTPA) was positive for a first PE and for whom an ECG taken at the 
time of presentation was available.  We matched these for age +/- 3 years with 189 controls 
with suspected PE whose CTPA was negative.  We considered those with large (n=76) and 
small (n=113) clot load separately.  We scored each ECG for the presence or absence of 8 
features that have been reported to occur more commonly in PE. 
Results – 20-25% patients with PE, including those with large clot load, had normal ECGs. 
The commonest ECG abnormality in patients with PE was sinus tachycardia (28%).  S1Q3T3 
(3.7%), p pulmonale (0.5%) and right axis deviation (4.2%) were infrequent findings.  RBBB 
(8.5%), atrial dysrhythmias (10.1%) and clockwise rotation (20.2%) occurred more 
frequently but were also common in controls.  Right ventricular (RV) strain pattern occurred 
more commonly in patients than controls, 11.2% v 2.7% (sensitivity 17.1%, specificity 
97.4%; odds ratio (OR) 4.58, 95% CI 1.63, 15.91; p=0.002), particularly in those with large 
clot load, 17.1% v 2.6%, (sensitivity 17.1%, specificity 97.4%; OR 7.55, 95%CI 1.62, 71.58; 
p=0.005).   
Conclusion – An ECG showing RV strain in a breathless patient is highly suggestive of PE.   
Many of the other ECG changes that have been described in PE occur too infrequently to be 
of predictive value. 
Word count 245  
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Main messages 
 The ECG finding that best predicted PE in our study was RV strain pattern.    
 S1Q3T3 was uncommon in our study.  
 An ECG showing RV strain when present in a breathless patient is highly suggestive 
of PE. 
 Many of the other ECG changes that have been described in PE occur too 
infrequently to be of predictive value. 
 
Research questions 
 It would be interesting to repeat the study in all patients undergoing CTPA and not 
simply those who had both D-dimer and CTPA. 
 We used an estimate of clot load rather than right ventricular dilation as our index of 
PE severity.  It is possible that RV dilation would have been a better marker of 
severity. 
 The use of biochemical markers such as high sensitivity troponin and NT Pro BNP 
could be used to further refine the assessment of severity. 
 
Key Words 
 Electrocardiogram 
 Right ventricular strain pattern 
 Pulmonary embolism 
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Introduction 
 
Pulmonary Embolism is one of the most common cardiovascular diseases with 47,594 cases 
reported in the UK in 2013[1].   The majority of pulmonary artery emboli result from the 
propagation of a deep vein thrombosis (70-80%)[2].   Pulmonary embolism is the most 
common cause of vascular death after myocardial infarction and stroke and the leading cause 
of preventable death in patients admitted to hospital[3].   It is a common mode of death in 
patients with cancer, stroke and pregnancy[4]. 
Pulmonary embolism may be categorised as massive, submassive or low risk based on the 
presence or absence of hypotension and right ventricular dysfunction[5].   Most but not all 
patients with PE will have risk factors for venous thromboembolism, the most frequently 
reported of which is immobilisation[3].  The commonest presenting symptoms are dyspnoea 
and pleuritic pain but both may be absent even in patients with large clot load[6].   Clinical 
probability scores and D-dimer are recommended in order to determine which patients should 
have computed tomographic pulmonary angiography (CTPA) but it is well recognised that 
patients with low probability scores can have PE with large clot load[6] while D-dimer has 
low specificity for PE and is best regarded as a rule out test[7]. 
The role of the ECG in PE remains controversial.  It is generally accepted that the ECG is of 
limited value in diagnosis but may predict a poor outcome when abnormal.  A number of 
ECG changes have been reported to occur more commonly in PE including sinus tachycardia, 
right bundle branch block (RBBB), right ventricular strain pattern, right axis deviation, p 
pulmonale, S1Q3T3 pattern, clockwise rotation and atrial dysrhythmias[8,9]. Right 
ventricular strain pattern is recognized by simultaneous T wave inversion in the inferior (II, 
III, avF) and right precordial leads (V1-4) (Fig 1).  These changes are considered to reflect 
right ventricular dysfunction in patients with large clot load[10-12] and have been shown to 
predict a poorer outcome when present[8-10,13-15]. Clockwise rotation is said to occur 
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when the transition zone from dominant S wave to dominant R wave occurs after V4.  
This can occur in normal subjects, in heart failure and also in patients with acute or 
chronic pulmonary disease. 
Figure 1 about here  
It is our belief that these ECG changes might also be a clue to diagnosis and that failure to 
recognise the significance of these changes in a breathless patient might lead to a delayed or 
incorrect diagnosis.  A difficulty here is that the changes described can occur in patients with 
other causes of right ventricular dysfunction such as chronic lung disease[16] and that similar 
but subtly different changes may be present in acute coronary syndrome (ACS), though in 
ACS with T wave inversion in leads V1–V4 it would be unusual to find T wave inversion in 
leads III and aVF as well [17,18]. 
 
In order to address these issues further we have investigated the diagnostic value of 
prespecified ECG changes for PE in a cohort of patients all of whom were suspected of 
having PE and all of whom underwent CTPA.    
 
Methods 
 
This was a retrospective study carried out in Dumfries and Galloway Royal Infirmary, a 
district general hospital covering a population of 147,000 in southwest Scotland.   We 
selected patients for inclusion if they had presented as an emergency and had both D-dimer 
and CTPA for suspected pulmonary embolism between September 2012 and March 2016[7].  
From a cohort of 1397 patients with suspected PE we identified 189 whose CTPA was 
positive for a first PE and for whom an ECG taken at the time of presentation was available.  
We considered patients with large (n=76) and small (n=113) clot load separately[12] (Figure 
2).   We then matched patients for gender and age ± 3 years with 189 controls whose CTPA 
were negative.  Patients were either admitted to hospital or discharged following CTPA either 
because this was negative or because we felt their PE could be managed safely in an 
ambulatory setting.   
Figure 2 about here 
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We screened for the presence of cardiorespiratory disease by retrospective analysis of the 
electronic case note in order to identify conditions that might contribute to altered signal or 
‘noise’ on the ECG.   We defined pre-existing cardiorespiratory disease as myocardial 
infarction (MI), chronic obstructive pulmonary disease (COPD), pulmonary hypertension 
(PHTN), pulmonary fibrosis (PF) or obstructive sleep apnoea (OSA).    If we were unable to 
find this information in the admission document we searched GP referrals and clinic letters.   
To be certain that we did not miss cases of OSA, we cross checked a database of patients that 
were known to the local sleep service.  It had been our intention to match cases and controls 
for not only for age and sex but also for cardiorespiratory disease though there were too few 
controls to do this.  We were able, however, to match 87 CTPA positive patients with 87 
controls suspected of having PE whose CTPAs were negative, for age, sex and absence of 
cardiorespiratory disease 
 
We printed CTPA reports for all case and controls and assigned each a unique reference 
number.   We defined large clot load as PE in pulmonary trunk/ main pulmonary artery and 
either the lobar arteries or the remote branches; and small clot load as PE confined to lobar 
arteries or remote branches[12].  The radiologist (PH) who reviewed the CTPAs did so 
without knowledge of the ECG findings.   We printed ECGs for all cases and controls from 
the electronic case note for analysis by a cardiologist (AM).  Most patients had more than one 
ECG during their admission.   When more than one ECG was present we selected the highest 
quality ECG that was most closely related in time to its respective CTPA.   AM scored each 
ECG for the presence or absence of 8 features that have been reported to occur more 
commonly in PE[9] (Table 1) without knowledge of the CTPA result.   
For each ECG finding and each patient group (all patients and subgroups by clot load and 
absence of cardiorespiratory disease), we calculated sensitivity and specificity for identifying 
PE, along with binomial confidence intervals, odds ratios with 95% confidence limits and p-
values from exact Fisher tests comparing cases and controls[19]. 
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ECG   finding Definition  
Sinus tachycardia HR > 100bpm 
Complete or 
incomplete RBBB 
QRS duration >120ms with rSR pattern V1-V3 
Right ventricular 
strain pattern 
Simultaneous T wave inversion in the inferior (II, III, 
avF) and right precordial leads (V1-4).  
Right axis deviation Dominant S wave lead I with dominant R wave leads II 
and III  
P pulmonale Peaked P waves >2.5mm in limb leads or >1.5mm in lead 
V1.  
S1Q3T3 pattern The presence of S waves in lead 1 and Q waves in lead 
III, each with amplitudes >1.5mmm in association with 
negative T waves in lead III.  
Clockwise rotation Shift of the R/S transition point (the point at which the R 
wave becomes dominant) to V5 or beyond implying 
rotation of the heart due to ventricular dilation.  
Atrial 
tachyarrthythmias 
Atrial Fibrillation and Atrial Flutter.  
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Table 1. ECG changes said to occur more commonly in PE 
 
Results 
Our cohort of 189 patients with PE comprised 82 men and 107 women, average age 66 years 
with age range 20-93 years. Seventy six (40%) were judged to have large clot load and 87 
(46%) no evidence of pre-existing cardiorespiratory disease. The distribution of pre-existing 
cardiorespiratory disease in patients and their age and sex matched controls is shown in 
figure 3 which illustrates that more control patients had COPD.   
Figure 3 about here 
 
 Twenty to twenty five percent of patients with PE, including those with large clot load, had 
normal ECGs (Table 2).  The commonest ECG finding in patients with PE was sinus 
tachycardia though this was not invariable: around 70% patients with large clot load had 
heart rates <100/min.  S1Q3T3 (3.7%), p pulmonale (0.5%) and right axis deviation (4.2%) 
were infrequent findings.  RBBB (8.5%), atrial dysrhythmias (10.1%) and clockwise rotation 
(20.2%) occurred more frequently but were also common in controls.  Right ventricular (RV) 
strain pattern occurred more commonly in patients than controls (11.2% v 2.7%, p=0.002), 
particularly in those with large clot load (17.1% v 2.6%, p=0.005) (Table 2). 
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Table 2.   Frequency of ECG findings for all patients and controls, and for subgroups by clot load and absence of 
cardiorespiratory disease. 
 
ECG finding              All cases                                  Large clot load                Small clot load                     
 
No cardiorespiratory 
disease 
 Cases (%)  Controls (%)       Cases (%)  Controls (%) Cases (%)  Controls (%) Cases (%)  Controls (%) 
 
Patients   
189 (100)    189 (100) 76 (100)     76 (100) 113 (100)   113 (100) 87 (100)      87 (100) 
Normal ECG 43 (22.7)      58 (30.7)  16 (21.1)    24 (31.6) 27 (23.9)     34 (30.1) 20 (23.0)       30 (34) 
Any Abnormality 146 (77.2)    131 (69.3) 60 (78.9)    52 (68.4) 86 (76.1)     79 (69.9) 67 (77.0)        57 (66) 
Sinus Tachycardia 52 (27.5)      38 (20.1) 22 (28.9)    14 (18.4) 30 (26.5)     24 (21.2) 27 (31.0)       16 (18) 
RBBB 17 (9.0)        17 (9.0) 8 (10.5)       5 (6.6) 9 (8.0)         12 (10.6) 8 (9.2)            6 (7) 
RV Strain 21 (11.1)       5 (2.6) 13 (17.1)     2 (2.6) 8 (7.1)         3 (2.7) 9 (10.3)          1 (1) 
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ECG finding              All cases                                  Large clot load                Small clot load                     
 
No cardiorespiratory 
disease 
 Cases (%)  Controls (%)       Cases (%)  Controls (%) Cases (%)  Controls (%) Cases (%)  Controls (%) 
RAD 8 (4.2)           5 (2.6) 2 (2.6)         2 (2.6) 6 (5.3)         3 (2.7) 1 (1.1)            0 (0) 
P pulmonale 1 (0.5)           0 (0.0) 1 (1.3)         0 (0.0) 0 (0.0)         0 (0.0) 1 (1.1)            0 (0) 
S1Q3T3 7 (3.7)           1 (0.5) 5 (6.6)         1 (1.3) 2 (1.8)         0 (0.0) 4 (4.6)            0 (0) 
Clockwise Rotation 38 (20.1)       29 (15.3) 15 (19.7)     12 (15.8) 23 (20.4)     17 (15.0) 15 (17.2)        16 (18) 
Atrial Tachyarrhythmias 19 (10.1)       24 (12.7) 7 (9.2)          9 (11.8) 12 (10.6)     15 (13.3) 6 (6.9)            11 (13) 
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Tables 3 and 4 show sensitivities, specificities and odds ratios for each of the 8 ECG 
abnormalities for all patients, and for patients with large clot load, small clot load and no pre-
existing cardiorespiratory disease separately.  Sensitivity for each individual ECG finding 
was always lower than specificity and never more than 31% which is too low for the ECG to 
be considered a rule out test in patients suspected of having PE.  Specificity approached 
100% for RV strain, RAD, p pulmonale and S1Q3T3 but with the possible exception of RV 
strain the prevalence of these ECG abnormalities was too low for the ECG to be of value as a 
rule in test.  RV strain, which was present in 11.1% of all cases, 17.1% cases with large clot 
load and 10.3% of those with no pre-existing cardiorespiratory disease, was associated with 
specificities of 97.4% (95% CI 93.9,99.1%), 97.4% (95% CI 90.8,99.7%) and 98.9%  (95% 
CI 93.8,100.0%) respectively (Table 3).   Corresponding odds ratios were 4.58, 7.55 and 9.82 
though confidence intervals were wide (Table 4).  Sensitivities were higher (76-79%) and 
specificities lower (27-35%) when we combined all ECG findings and considered any ECG 
abnormality.   We did not calculate positive and negative predictive values as these are 
prevalence dependent risk factors and this was a case control study.  
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Table 3 Sensitivities and specificities in % for all patients and subgroups by clot load and absence of 
cardiorespiratory disease, with binomial 95% zconfidence intervals  
 
ECG finding  All cases Large clot load Small clot load 
No cardiorespiratory  
disease  
Normal ECG 
Sensitivity 
Specificity 
22.8 (17.0, 29.4) 
69.3 (62.2, 75.8) 
21.1 (12.5, 31.9) 
68.4 (56.7, 78.6) 
23.9 (16.4, 32.8) 
69.9 (60.6, 78.2) 
23.0 (14.6, 33.2) 
65.5 (54.6, 75.4)  
Any Abnormality 
Sensitivity 
Specificity 
77.2 (70.6, 83.0) 
30.7 (24.2, 37.8) 
78.9 (68.1, 87.5) 
31.6 (21.4, 43.3) 
76.1 (67.2, 83.6) 
30.1 (21.8, 39.4) 
77.0 (66.8, 85.4) 
34.5 (24.6, 45.4)  
Sinus 
Tachycardia 
Sensitivity 
Specificity 
27.5 (21.3, 34.5) 
79.9 (73.5, 85.4) 
28.9 (19.1, 40.5) 
81.6 (71.0, 89.5) 
26.5 (18.7, 35.7) 
78.8 (70.1, 85.9) 
31.0 (21.5, 41.9) 
81.6 (71.9, 89.1)  
RBBB 
Sensitivity 
Specificity 
9.0 (5.3, 14.0) 
91.0 (86.0, 94.7) 
10.5 (4.7, 19.7) 
93.4 (85.3, 97.8) 
8.0 (3.7, 14.6) 
89.4 (82.2, 94.4) 
9.2 (4.1, 17.3) 
93.1 (85.6, 97.4)  
RV Strain 
Sensitivity 
Specificity 
11.1 (7.0, 16.5) 
97.4 (93.9, 99.1) 
17.1 (9.4, 27.5) 
97.4 (90.8, 99.7) 
7.1 (3.1, 13.5) 
97.3 (92.4, 99.4) 
10.3 (4.8, 18.7) 
98.9 (93.8, 100.0)  
RAD 
Sensitivity 
Specificity 
4.2 (1.8, 8.2) 
97.4 (93.9, 99.1) 
2.6 (0.3, 9.2) 
97.4 (90.8, 99.7) 
5.3 (2.0, 11.2) 
97.3 (92.4, 99.4) 
1.1 (0.0, 6.2) 
100.0 (95.8, 100.0)  
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Table 3 Sensitivities and specificities in % for all patients and subgroups by clot load and absence of 
cardiorespiratory disease, with binomial 95% zconfidence intervals  
 
ECG finding  All cases Large clot load Small clot load 
No cardiorespiratory  
disease  
P Pulmonale 
Sensitivity 
Specificity 
0.5 (0.0, 2.9) 
100.0 (98.1,100.0) 
1.3 (0.0, 7.1) 
100.0 (95.3,100.0) 
0.0 (0.0, 3.2) 
100.0 (96.8, 100.0) 
1.1 (0.0, 6.2) 
100.0 (95.8, 100.0)  
S1S2S3 
Sensitivity 
Specificity 
1.6 (0.3, 4.6) 
98.4 (95.4, 99.7) 
2.6 (0.3, 9.2) 
98.7 (92.9, 100.0) 
0.9 (0.0, 4.8) 
98.2 (93.8, 99.8) 
2.3 (0.3, 8.1) 
100.0 (95.8, 100.0)  
S1Q3T3 
Sensitivity 
Specificity 
3.7 (1.5, 7.5) 
99.5 (97.1, 100.0) 
6.6 (2.2, 14.7) 
98.7 (92.9, 100.0) 
1.8 (0.2, 6.2) 
100.0 (96.8, 100.0) 
4.6 (1.3, 11.4) 
100.0 (95.8, 100.0)  
Clockwise 
Rotation 
Sensitivity 
Specificity 
20.1 (14.6, 26.5) 
84.7 (78.7, 89.5) 
19.7 (11.5, 30.5) 
84.2 (74.0, 91.6) 
20.4 (13.4, 29.0) 
85.0 (77.0, 91.0) 
17.2 (10.0, 26.8) 
81.6 (71.9, 89.1)  
Atrial 
Tachyarrthythmia
s 
Sensitivity 
Specificity 
10.1 (6.2,15.3) 
87.3 (81.7, 91.7) 
9.2 (3.8, 18.1) 
88.2 (78.7, 94.4) 
10.6 (5.6, 17.8) 
86.7 (79.1, 92.4) 
6.9 (2.6, 14.4) 
87.4 (78.5, 93.5)  
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Table 4 Odds ratios for ECG as predictor of pulmonary embolism for all patients and subgroups by clot 
load and absence of cardiorespiratory disease. 
 
ECG 
finding 
All Large clot load Small clot load 
No cardiorespiratory 
disease  
 OR (95%CI)              p                              OR (95%CI)              p                              OR (95%CI)              p                              OR (95%CI)              p                              
Normal 0.67 (0.41, 1.08),     0.103 0.58 (0.26, 1.28),     0.197 0.73 (0.39, 1.37)    0.369 0.57 (0.27, 1.16),     0.131  
Any  
Abnormality 
1.50 (0.93, 2.45),     0.103 1.72 (0.78, 3.88),     0.197 1.37 (0.73, 2.59)    0.369 1.76 (0.86, 3.65),     0.131  
Sinus 
Tachycardi
a 
1.51 (0.91, 2.51),     0.116 1.80 (0.79, 4.20),     0.181 1.34 (0.69, 2.61)    0.436 1.99 (0.93, 4.35),     0.078  
RBBB 1.00 (0.46, 2.16),     1.000 1.67 (0.45, 6.80),     0.564 0.73 (0.26, 1.98)    0.648 1.36 (0.39, 5.00),     0.782  
RV Strain 4.58 (1.63, 15.91),   0.002 7.55 (1.62, 71.58),   0.005 2.78 (0.65, 16.71)  0.215 9.82 (1.31, 438.97), 0.018  
RAD 1.62 (0.46, 6.44),     0.573 1.00 (0.07, 14.13),   1.000 2.05 (0.42, 12.99)  0.499                                 1.000  
P 
Pulmonale 
                                1.000                                 1.000                               1.000                                 1.000  
S1S2S3 1.00 (0.13, 7.56),     1.000 2.02 (0.10, 121.07), 1.000 0.50 (0.01, 9.67)    1.000                                 0.497  
S1Q3T3 7.20 (0.91, 327.08), 0.067 5.23 (0.57, 252.76), 0.209                               0.498                                 0.121  
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Table 4 Odds ratios for ECG as predictor of pulmonary embolism for all patients and subgroups by clot 
load and absence of cardiorespiratory disease. 
 
ECG 
finding 
All Large clot load Small clot load 
No cardiorespiratory 
disease  
 OR (95%CI)              p                              OR (95%CI)              p                              OR (95%CI)              p                              OR (95%CI)              p                              
Clockwise 
Rotation 
1.39 (0.79, 2.46),     0.281 1.31 (0.52, 3.33),     0.672 1.44 (0.69, 3.08)    0.384 0.92 (0.39, 2.17),    1.000  
Atrial 
Tachy-
arrthythmia
s 
0.77 (0.38, 1.53),     0.517 0.76 (0.23, 2.43),     0.792 0.78 (0.31, 1.88)    0.682 0.51 (0.15, 1.60),    0.307  
 
 
Table shows odds ratio, 95% confidence interval and p-value from Exact Fisher Test comparing cases and controls.   If the confidence interval  
does not have finite limits, only the p-value is displayed. 
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Discussion 
We believe that ours is the first study of the ECG as predictor of diagnosis in PE to use age 
and sex matched controls and also to consider clot load.   The ECG finding that best 
predicted PE was RV strain pattern.   S1Q3T3 was uncommon in our study. More of our 
control patients had COPD, suggesting that PE is frequently suspected but not confirmed in 
patients with COPD who present with worsening respiratory symptoms. 
S1Q3T3 and RV strain pattern, when present, are the two ECG changes most frequently 
associated with right ventricular dysfunction in PE.   S1Q3T3, probably the most well known 
ECG finding, was first described in 1935[20].  The frequency with which it occurs varies 
from 3.7%[21] to 50%[10], the higher figure reflecting the high proportion of patients with 
massive PE (76%) in that study.  The prevalence of  S1Q3T3 in our patients was 4% which is 
at the lower end of this range.  We recognise that the determination of S1Q3T3 pattern can 
sometimes be difficult, particularly in relation to the presence or absence of a small R wave 
in lead III and wonder if this might contribute at least in part to the variation in prevalence. 
The literature on the role of the ECG in the diagnosis of PE includes some who believe the 
ECG is of limited value[22,23], and others who feel that ECG changes are a possible clue to a 
diagnosis that must then be confirmed by CTPA[21,24]. Rodger and colleagues examined 
212 consecutive inpatients and outpatients with suspected PE.  All had a VQ scan and anyone 
with an indeterminate scan had pulmonary angiography.   PE was confirmed in 49 patients 
and excluded in 163.  Only sinus tachycardia and incomplete RBBB predicted PE in this 
dataset.   Patients and controls were not age or sex matched and no attempt was made to 
stratify by clot load or pre-existing cardiorespiratory disease.   These authors concluded that 
the ECG was of limited value in the diagnosis of PE[22].  Chan et al, reviewing the literature, 
came to a similar conclusion, namely that the overall utility of the electrocardiogram is 
limited due to the variable presence, frequency, and transient nature of most of the ECG 
abnormalities associated with the disease[23]. 
By contrast, Marchick and colleagues were able to show positive likelihood ratios for 
S1Q3T3 pattern and precordial T wave inversion among 6049 emergency department patients 
suspected of having PE, in 354 of whom a diagnosis was subsequently confirmed. No attempt 
was made to age or sex match patients and controls or to stratify by clot load, though their 
results were not influenced one way or another by the presence of pre-existing 
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cardiorespiratory disease[24]. More recently Co et al used patients as their own controls by 
comparing ECG at diagnosis with a previous ECG in a cohort of 352 PE patients.  Seventy 
six percent had a significant change in their ECG, most notably T wave inversions in just 
over one third of cases. These TWIs occurred in all leads but were most common 
inferiorly[21].  
How may these apparently conflicting views be reconciled?  The prevalence of RV strain 
varies from 7.3% (24) to 68% (10), reflecting the fact that most studies include a mixture of 
patients with large and small clot load.  In our study 76/189 (40%) patients were judged to 
have large clot load, a similar proportion to that reported by Co et al[21].  We might expect 
the ECG to be less predictive for PE in studies with a higher proportion of small PEs. It is 
also likely that studies with smaller numbers of patients may not have the power to detect the 
findings of right ventricular dysfunction.  Six of the 11 studies reviewed by Chan comprised 
50 or fewer patients[23].   
Strengths and limitations 
Our study has strengths and limitations.  Strengths are our comparison with age and sex 
matched controls, and stratification by clot load.  The fact that more control patients had pre-
existing cardiorespiratory disease may also be a strength as we were still able to show that 
RV strain predicted PE despite using controls likely to have RV strain for other reasons. We 
would have preferred to match cases and controls for presence or absence of 
cardiorespiratory disease but had too few control patients to enable us to do this.  Our main 
limitation is that we could find no electronic record for 96 of our 313 CTPA positive patients.  
It is likely that this group includes more patients with massive and submassive PE who died 
early during the course of their admission as case sheets for such patients are often sent 
straight to file and may not always be scanned.  We used an estimate of clot load rather than  
RV dilation as our index of PE severity.  RV dilation and biochemical markers such as high 
sensitivity troponin and NT-Pro BNP could further refine the assessment of severity.  We did 
not attempt to assess inter observer variability when analysing ECGs and CTPAs but 
eliminated interpretation bias by ensuring that our radiologist and cardiologist were unaware 
of each other’s findings. As this was a case control study, we made no attempt to calculate 
positive and negative predictive values as these are prevalence dependent factors.  
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Conclusion 
 
In conclusion, an ECG showing RV strain in a breathless patient with no previous history of 
cardiorespiratory disease is highly suggestive of PE with specificity 97.4% for large clot load.  
S1Q3T3 also has high specificity for PE but was a relatively uncommon finding in our study.  
Many of the other ECG changes that have been described in PE occur too infrequently to be 
of predictive value.   
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